Humasis (Korea) Today
| 205470 Stock | KRW 1,862 68.00 3.52% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Humasis is trading at 1862.00 as of the 22nd of November 2024, a 3.52 percent decrease since the beginning of the trading day. The stock's open price was 1930.0. Humasis has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Humasis Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. The company has 27.69 M outstanding shares. More on Humasis Co
Moving together with Humasis Stock
Moving against Humasis Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Humasis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Humasis' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Humasis or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Jeong Cha |
| Business Concentration | Health Care Equipment & Supplies, Healthcare (View all Sectors) |
Humasis Co (205470) is traded on KOSDAQ in Korea and employs 87 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 425.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Humasis's market, we take the total number of its shares issued and multiply it by Humasis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Humasis operates under Healthcare sector and is part of Health Care Equipment & Supplies industry. The entity has 27.69 M outstanding shares.
Humasis Co has accumulated about 176.58 B in cash with 205.02 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 962.18.
Check Humasis Probability Of Bankruptcy
Ownership AllocationHumasis Co has a total of 27.69 Million outstanding shares. Humasis retains 8.0 (percent) of its outstanding shares held by insiders and 0.26 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Humasis Ownership Details
Humasis Risk Profiles
Although Humasis' alpha and beta are two of the key measurements used to evaluate Humasis' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.91 | |||
| Standard Deviation | 6.59 | |||
| Variance | 43.45 | |||
| Risk Adjusted Performance | (0.02) |
Humasis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Humasis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Humasis Corporate Management
Elected by the shareholders, the Humasis' board of directors comprises two types of representatives: Humasis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Humasis. The board's role is to monitor Humasis' management team and ensure that shareholders' interests are well served. Humasis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Humasis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gwang Cho | Director | Profile | |
| Hyeong Kim | Internal Auditor | Profile | |
| Seong Yim | Non-Executive Independent Director | Profile | |
| Yin Cho | Non-Executive Independent Director | Profile | |
| Jeong Kim | Director | Profile | |
| Seok Lee | Director | Profile |
Other Information on Investing in Humasis Stock
Humasis financial ratios help investors to determine whether Humasis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humasis with respect to the benefits of owning Humasis security.